This inventor holds 2 USPTO granted patents. Top assignee: Forschungszentrum Julich Gmbh. Active years: 2006-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2009
Title: Reinhard Seifert: Innovator in Cardiovascular Research
Introduction
Reinhard Seifert is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of cardiovascular research through his innovative work in nucleic acids and ion channels. With a total of 2 patents, his inventions are paving the way for advancements in medical treatments.
Latest Patents
Seifert's latest patents focus on isolated or purified human nucleic acids, particularly DNA sequences encoding ion channels. One of his inventions relates to a vector that includes the isolated nucleic acid, a host cell containing the vector, and a composition that combines the nucleic acid with a carrier. This invention also encompasses a polypeptide or protein encoded by the nucleic acid, along with methods for treating mammals suffering from cardiovascular disorders. Another patent involves a nucleic acid that comprises part of the sequence of an ion channel, which may be derived from various sources, including human, rat, bovine, and sea urchin DNA. This invention also includes mRNA molecules containing the corresponding sequences and their applications in screening, diagnosing methods, and treatment of cardiovascular disorders.
Career Highlights
Reinhard Seifert is associated with Forschungszentrum Jülich GmbH, where he continues to contribute to groundbreaking research in his field. His work has garnered attention for its potential impact on medical science and treatment methodologies.
Collaborations
Seifert has collaborated with esteemed colleagues such as Wolfgang Bönigk and Renate Gauss, further enhancing the scope and depth of his research endeavors.
Conclusion
Reinhard Seifert's innovative contributions to cardiovascular research through his patents highlight the importance of nucleic acids and ion channels in medical science. His work continues to inspire advancements in treatment options for cardiovascular disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
